-
Name
MOFEBUTAZONE
- EINECS 218-641-1
- CAS No. 2210-63-1
- Density 1.14g/cm3
- Solubility DMSO (Slightly), Methanol (Slightly)
- Melting Point 102-104°C
- Formula C13H16 N2 O2
- Boiling Point °Cat760mmHg
- Molecular Weight 232.282
- Flash Point °C
- Transport Information
- Appearance
- Safety Moderately toxic by intravenous and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx.
- Risk Codes
-
Molecular Structure
- Hazard Symbols
- Synonyms 1-Phenyl-4-butyl-3,5-pyrazolidinedione;1-Phenyl-4-butylpyrazolidin-3,5-dione;1-Phenyl-4-n-butyl-3,5-dioxopyrazolidine;2-Phenyl-3,5-dihydroxy-4-butylpyrazolidine;4-Butyl-1-phenyl-3,5-dioxopyrazolidine;4-Butyl-1-phenyl-3,5-pyrazolidinedione;4-Butyl-3,5-dioxo-1-phenyltetrahydropyrazole;Arcobutine;Arcomonol Tablets;Butazone;Mobutazon;Mobutazone;Mobuzon;Mofebutazone;Mofesal;Monazan;Monazon;Monobutyl;Monofen;Monofenew;Monomil;Monophenylbutazone;Monorheumetten;Monozon;Mophebutazone;Mozol;NSC 73725;Reumatox;
- PSA 49.41000
- LogP 2.26460
Mobutazon Chemical Properties
Chemistry informtion about Mobutazon (CAS NO.2210-63-1) is:
IUPAC Name: 4-Butyl-1-Phenylpyrazolidine-3,5-Dione
Synonyms: Mofebutazone ; 2fdbp ; 2-Phenyl-3,5-Dihydroxy-4-Butylpyrazolidine ; 4-Butyl-1-Phenyl-3,5-Dioxopyrazolidine ; 4-Butyl-1-Phenyl-3,5-Pyrazolidinedione ; 4-Butyl-1-Phenyl-5-Pyrazolidinedione ; Arcomonoltablets ; Mobutazon
MF: C13H16N2O2
MW: 232.28
EINECS: 218-641-1
Density: 1.14 g/cm3
Following is the molecular structure of Mobutazon (CAS NO.2210-63-1) is:
Mobutazon Uses
Mobutazon (CAS NO.2210-63-1) is a drug used for joint and muscular pain.
Mobutazon Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 700mg/kg (700mg/kg) | behavioral: tremor behavioral: convulsions or effect on seizure threshold lungs, thorax, or respiration: dyspnea | Scientia Pharmaceutica. Vol. 37, Pg. 185, 1969. |
| mouse | LD50 | intravenous | 600mg/kg (600mg/kg) | Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 233, Pg. 365, 1958. | |
| mouse | LD50 | subcutaneous | 920mg/kg (920mg/kg) | behavioral: tremor lungs, thorax, or respiration: dyspnea behavioral: convulsions or effect on seizure threshold | Scientia Pharmaceutica. Vol. 37, Pg. 185, 1969. |
| rat | LD50 | intraperitoneal | 848mg/kg (848mg/kg) | Farmaco, Edizione Scientifica. Vol. 14, Pg. 347, 1959. | |
| rat | LD50 | oral | 1750mg/kg (1750mg/kg) | Pharmaceutica Acta Helvetiae. Vol. 39, Pg. 155, 1964. |
Mobutazon Safety Profile
Moderately toxic by intravenous and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx.
Mobutazon Specification
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View